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Background: Neurotrophic factors have been implicated in hyperalgesia and peripheral levels of these molecules
are altered in migraine pathophysiology. Artemin, a vasculature-derived neurotrophic factor, contributes to pain
modulation and trigeminal primary afferent sensitization through binding its selective receptor GFRα3. The
distribution of artemin and GFRα3 in the dura mater raises an anatomy supports that they may be involved in
migraine. In this study we evaluated the expression of artemin and GFRα3 in an animal migraine model that may
be relevant for migraine.
Methods: In this study, using a rat migraine model by administration of nitroglycerin (NTG), we investigated the
expression of artemin in the dura mater and GFRα3 in the trigeminal ganglia (TG) by means of quantitative reverse
transcription-polymerase chain reaction, western blot and immunofluorescence labeling.
Results: Artemin immunoreactivity was found in the smooth muscle cells of dural vasculature and GFRα3 was
present in cytoplasm of TG neurons. The mRNA levels of artemin and GFRα3 were significantly elevated after NTG
treatment at 2 and 4 h respectively (P < 0.05). The expression of artemin protein was increased at 4 h and continually
up to 8 h in the dura mater following NTG administration (P < 0.05). The expression of GFRα3 protein was elevated at
4 h and continually up to 10 h in the TG following NTG administration (P < 0.05).
Conclusion: The findings suggest that artemin and GFRα3 play an important role in the pathogenesis of migraine and
may represent potential therapeutic targets for the treatment of migraine.
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Abbreviations: CGRP, Calcitonin gene related peptide; DRG, Dorsal root ganglia; GDNF, Glial cell line-derived
neurotrophic factor; GFRα3, GDNF family receptor alpha 3; NO, Nitric oxide; NS, Normal saline; NTG, Nitroglycerin;
PBS, Phosphate-buffered solution; qRT-PCR, Quantitative real-time reverse transcription-polymerase chain reaction;
TG, Trigeminal ganglia; TRPV1, Transient receptor potential vanilloid 1; α-SMA, α-smooth muscle actinBackground
Migraine is a common neurovascular disorder charac-
terized by recurrent attacks of typically throbbing and
unilateral headache, which affects up to 20 % of the
population [1]. However, its pathophysiology has not
yet been fully elucidated. To date, on the basis of* Correspondence: fanzment@outlook.com
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ories have been proposed for the mechanisms underlying
this disorder. In particular, one theory, which focuses on
the trigeminovascular system, has been widely accepted in
migraine pathogenesis [2, 3]. Many studies indicate that
activation of peripheral trigeminal nociceptors in the dura
mater results in the release of neuropeptides and neuro-
trophins, which are related to the generation and modula-
tion of migraine pain [4, 5].
In recent years, artemin, a member of the glial cell
line-derived neurotrophic factor (GDNF) family, hasis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
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lates the development and function of sensory neurons
[6, 7], but also participates in the pathophysiology of
peripheral inflammation and pain hyperalgesia [8].
Artemin exerts its influence on intracellular signaling
pathways via binding to the receptor complex of GDNF
family receptor alpha 3 (GFRα3) and ret [9]. GFRα3, a
highly selective receptor for artemin, is co-expressed with
the transient receptor potential vanilloid 1 (TRPV1) in the
dorsal root ganglia (DRG) and trigeminal ganglia (TG)
[10, 11]. TRPV1, a calcium permeable ion channel, is acti-
vated by heat and capsaicin, and is considered to play a
major role in the pathogenesis of migraine [12, 13]. In
addition, the detection of the distribution of artemin and
its receptor GFRα3 in the dura mater of rats suggests
that artemin may contribute to migraine pain by the
sensitization of dural afferents [11].
It is known that systemic administration of nitroglycerin
(NTG), a nitric oxide (NO) donor, can induce delayed
headaches in both migraneurs and healthy people [14],
and NTG-treated rodents have been found to be predict-
ive animal models of migraine [15]. Previous reports have
shown that the rat migraine model triggered by NTG
present vasodilation of the meningeal vessels and lead to
the release of proinflammatory substances [16]. In this
regard, the present study was designed to evaluate the
expression of artemin in the dura mater and GFRα3 in the
TG following NTG administration, so as to explore the
possible mechanisms of artemin and GFRα3 underlying
the pathogenesis of migraine.
Methods
Male wistar rats (weight 260–300 g) were purchased from
Animal Centre of Shandong University (Jinan, China) and
maintained in a humidity-controlled as well as thermoregu-
lated vivarium with a 12-h light/dark cycle. The animal care
and experimental protocol were approved by the Animal
Care Committee of Shandong University, PR China (NO.
ECAESDUSM 20123011).
Eighty wistar rats were stochastically divided into
three groups: normal control, normal saline (NS) con-
trol, and the NTG groups. NTG at dose of 10 mg/kg
was injected cervical subcutaneously to set up the rat
model of migraine [17]. In the NS group, rats were
treated with isotonic saline using the same volume as
NTG. At different time points after NTG or NS treat-
ment, rats were anaesthetized with 10 % chloral hydrate
(4 μl/g). Then the temporal bones were removed and
the dura was carefully dissected out. After removing
the brain halves, the TG tissues were separated from
the cranial base. Some tissue samples were quickly
frozen at −80 °C for further western blot analysis and
qRT-PCR, others were fixed in 4 % paraformaldehyde
for immunofluorescent staining.Quantitative reverse transcription-polymerase chain
reaction (qRT-PCR)
Total RNA was extracted from the dura mater and TG
using the Trizol Reagent (Invitrogen, Gaithersburg, USA)
according to the manufacturer’s instructions. For each
sample, 1 μg total RNA was reverse transcribed using the
ExScript RT reagent kit (TaKaRa, Dalian, China). Using
SYBR Green PCR kits, qPCR was performed on an
Eppendorf AG 22331 Hamburg machine (Germany).
Forward and reverse primer sequences applied in real-








CACGATTT-3′. The calculated number of specific tran-
scripts was normalized by β-actin or GAPDH. The real-
time value for each sample was averaged and compared by
using the CT method. The amount of target RNA (2-ΔΔCt)
was normalized both with the endogenous β-actin or
GAPDH reference (ΔCt) and theamount of target gene in
control sample, which was set as the calibrator at 1.0.
Western blot analysis
Total protein was extracted using radioimmune precipi-
tation buffer protein lysis buffer according to protocols
(Beyotime, Shanghai, China). The protein content of the
samples was measured by means of the BCA protein assay
kit (Beyotime, Shanghai). The protein samples were dena-
tured and separated by 10 % sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membranes. The nitrocellulose membranes
were blocked for 1 h at room temperature in 5 % skimmed
dried milk. Then the membranes were incubated with
primary antibodies including: rabbit antibody to GFRα3
(1:1000, Abcam Systems, USA), rabbit antibody to artemin
(1:200, Abbiotec, San Diego) and mouse antibody to β-
actin (1:1000, Santa Cruz Biotechnology, USA) in TBST
containing 3 % fat-free dry milk for 1 h at room
temperature and overnight at 4 °C. After washing 3 times
with TBST, the membranes were incubated with the sec-
ondary donkey anti-rabbit or anti-mouse IgG antibodies
(1:5000, Santa Cruz, USA) at room temperature for 1 h.
Finally, the immunoblots were detected using an ECL kit
(Santa Cruz, USA) and visualized after exposure to X-ray
films. The relative optical density ratio was calculated with
the Image J software by comparison to GAPDH or β-actin.
Immunofluorescence staining
Tissues were fixed in 4 % paraformaldehyde at 4 °C for
24 h, followed by incubated in 30 % sucrose for 24 h,
Fig. 1 Alteration of artemin mRNA expression in the dura mater
after NTG treatment. The expression of artemin (Artn) mRNA was
significantly increased at 2 h, 4 h following NTG treatment compared
with that in the normal control group (**P< 0.01, *P< 0.05). No significant
change in NS control group was observed compared to normal control
group. The data shown here were mean ± SEM of three separate
experiments
Fig. 2 Increased protein level of artemin in the dura mater following
NTG treatment. Western blots for artemin (Artn) and β-actin proteins
in the dura mater after NTG treatment. The protein expression of
Artn was dramatically elevated at 4, 6 and 8 h compared to normal
control group (**P < 0.01, *P < 0.05). There was no significant difference
between NS control group and normal control group. The data shown
here were mean ± SEM of three separate experiments
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for 24 h, quickly frozen with liquid nitrogen, and cut
into 6 μM sections using a cryostat (Leica CM 1850,
Nussloch, Germany). For immunofluorescence, samples
were washed in 0.01 M PBS and blocked in PBS contain-
ing 0.3 % Triton X-100 (Sigma, USA) and 10 % donkey
serum (NQBB, USA) for 1 h at room temperature and
incubated in primary antibodies overnight at 4 °C. The
following antibodies were used: goat antibody to GFRα3
(1:50, R&D Systems, USA), rabbit antibody to artemin
(1:50, Abbiotec, San Diego) and mouse antibody to α-
smooth muscle actin (α-SMA) (1:50, Dako Cytomation,
Germany), After being washed fully in PBS, samples were
incubated with secondary antibodies (1:1000, Invitrogen,
USA) and 49,6-diamidino-2-phenylindole (DAPI) (1:1000,
Molecular Probes, USA) in PBS at room temperature for
1 h. Then rinsed in PBS for 30 min. Immunofluorescent
samples were visualized with an inverted DMI 400CS
confocal microscope (Leica, Germany).
Statistical analysis
The statistical analyses were performed using SPSS 17.0
software (SPSS Inc., Chicago, ILL, USA). Data were
expressed as mean ± standard error of the mean (SEM).
One-way Analysis of variance (ANOVA) was used for
statistical analysis and P < 0.05 was considered statisti-
cally significant.
Results
Expression of artemin in the dura mater
In consideration of NTG-induced delayed onset inflam-
mation in migraine model rats, the mRNA expression of
artemin in the dura mater was detected after NTG or
NS administration for 2, 4 and 6 h each. As shown in
Fig. 1, the mRNA level of artemin was significantly ele-
vated at 2 and 4 h after NTG administration compared
to the normal control group. There was no significant
difference in artemin mRNA expression between the NS
control group and the normal control group.
Four time points (2, 4, 6 and 8 h) were chosen to
evaluate the protein level of artemin in the dura mater
following NTG or NS injection. As shown in Fig. 2, the
expression of artemin protein was low in both normal
control group and NS control group. However, the pro-
tein expression of artemin in the dura of rats after NTG
injection from 4 to 8 h was dramatically increased com-
pared with that in the normal control rats.
Expression of GFRα3 in the TG
The mRNA expression of GFRα3 in the TG was detected
after NTG or NS administration for 2, 4 and 6 h each. As
shown in Fig. 3, the mRNA level of GFRα3 in the TG was
markedly increased at the 4-h time point after NTG
administration compared to the normal control group.There was no significant difference in GFRα3 mRNA ex-
pression between the NS control group and the normal
control group.
Five time points (2, 4, 6, 8, and 10 h) were chosen to
evaluate the protein level of GFRα3 in the TG after
Fig. 3 Alteration of GFRα3 mRNA expression in the TG after NTG
treatment. The expression of GFRα3 mRNA was significantly increased
at 4 h following NTG treatment compared with that in the normal
control group (**P < 0.01). No significant change in NS control group
was observed compared to normal control group. The data shown
here were mean ± SEM of three separate experiments
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of GFRα3 protein was low in both normal control group
and NS control group. However, the protein expression
of GFRα3 in the TG after NTG injection from 4 to 10 h
was markedly increased compared with that in the normal
control rats.Fig. 4 Increased protein level of GFRα3 in the TG following NTG
treatment. Western blots for GFRα3 and GAPDH proteins in the TG
after NTG treatment. The protein expression of GFRα3 was dramatically
elevated at 4 h and continually up to 10 h compared to normal control
group (**P< 0.01, *P< 0.05). There was no significant difference between
NS control group and normal control group. The data shown here were
mean ± SEM of three separate experimentsImmunofluorescence labeling for artemin and GFRα3
Double immunofluorescence labeling proved the co-
localization of artemin and α- smooth muscle actin (α-
SMA), a maker for smooth muscle cells, on the dural
blood vessels. Additionally, the immune positive signal
of artemin that it was observed after NTG was obviously
enhanced than that of NS-treated control rats. Meanwhile,
some artemin was secreted out the smooth muscle cells of
dural vasculature (Fig. 5a-f).
Double immunofluorescence showed that low level of
GFRα3 was present in the cytoplasm of TG neurons. In
addition, an increased number of GFRα3 immunoreac-
tivity neurons in the TG were observed in NTG group
compared to the NS control group (Fig. 5j-l).Discussion
NTG, an exogenous NO donor, is known to induce
migraine-like headache in migraineurs and rodents [18].
Systemic administration of NTG has been reported to
cause inflammation and sensitization of primary affer-
ents of the trigeminovascular system [19–21]. In this
study, we explored the locations and expression of arte-
min and its selective receptor GFRα3 in an animal
model of migraine, with special attention given to their
possible involvement in the pathogenesis of migraine.
In recent years, the role of artemin in mediating
neuropathic and inflammatory pain has been paid much
attention [8, 22]. The level of artemin is known to be
elevated after peripheral inflammation or nerve injury
[7, 8]. It has been demonstrated that infusion of NTG
lead to vasodilation of the meningeal blood vessels and
then modulate the inflammatory factors release [23]. In
this study, we found that both the mRNA and protein
levels of artemin in the dura mater were up-regulated
following NTG administration. In the time course of
NTG-induced mRNA and protein expression levels of
artemin we found a delayed response, which was consist-
ent with delayed meningeal inflammation of earlier stud-
ies. In their reports, migraine attacks do not occur
immediately after NTG administration with the vasodila-
tory effects of the drug, but rather after 2 to 6 h [21, 24].
The trends of the mRNA expression apparently were
mismatched with that of protein expression, which
might be due to the delayed expression from mRNA to
functional receptor protein. In addition, artemin was
shown to be located in the smooth muscle cells of dural
vasculature, which was in agreement with a study by
McIlvried, who firstly reported the expression of artemin
in the dura mater of rats [11]. Moreover, in a migraine
model, our findings supplied the firsthand evidence that
the immunfluorescence intensity of artemin was obvi-
ously up-regulated and a certain amount of artemin was
secreted out the smooth muscle cells of the dural vascular,
Fig. 5 Immunostaining of artemin in the dura mater and GFRα3 in the TG after NTG treatment. a-c Immunohistochemical staining for α-SMA
(red) and artemin (Artn, green) in the dura mater of NS control group. d-f Artemin was strongly expressed in the dura mater after NTG treatment.
g-i Immunohistochemical staining for DAPI (blue) and GFRα3 (green) in the TG of NS control group. j-l The number of GFRα3-positive neurons
was elevated after NTG treatment. c, f, i, l The same field of merged vision. Scale bar = 100 μm
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contribute to the dural inflammation of migraine pain.
Artemin exerts its roles in intracellular signaling path-
ways through the receptor complex of ret and GFRa3,
and recent studies suggest that GFRa3 was present in
trigeminal afferents that innervate the dura [9, 11]. To
further explore the possible roles of artemin in migraine,
the alterations in its selective receptor GFRα3 in re-
sponse to NTG were continually determined. We found
that both the mRNA and protein levels of GFRα3 in the
TG were substantially up-regulated as a result of the
NTG injection. Meanwhile, the number of GFRα3 im-
munoreactive TG neurons was increased after NTG
treatment, indicating that the release of artemin from
the vascular smooth muscle cells may activate the periph-
eral trigeminal nerve via binding GFRα3 in a rat migraine
model. Some observations have shown that GFRα3 ap-
peared to be present in similar subpopulations of noci-
ceptive afferents in the TG [10, 25], which suggeststhat artemin and GFRα3 might play a particularly
important role in nociceptive processing in the tri-
geminal system and consequently contribute to the
pathology of migraine.
Previous studies have reported that overexpression of
artemin in skin and tongue enhances expression of noci-
ceptor TRPV1 in DRG and TG, thereby leading to behav-
ioral and oral sensitivity [8, 26]. Moreover, activation of
TRPV1 has been shown to promote the release of calci-
tonin gene-related peptide (CGRP) from trigeminal nerve
terminals, which contribute to the neurogenic inflam-
mation in the initiation of a migraine attack [27, 28].
However, other studies suggest that TRPV1 has no effect
on the pathogenesis of migraine and TRPV1 antagonists
are not effective for migraine treatment [29–31]. Thus, the
role of the TRPV1 in migraine pain is still controversial to
date, and the downstream regulatory mechanisms under-
lying the actions of artemin and GFRα3 on migraine pain
require to be studied further.
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In summary, our study revealed that the enhanced activities
of artemin and GFRα3 might be critical processes in
migraine pathogenesis and serve as the possible key fac-
tor in inducing migraine pain. Taken together, artemin
and its selective receptor GFRα3 might be novel targets
for therapeutic strategies of migraine.
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